Nieuws
More than EUR 56 million raised to fund initiative to fight antibiotic resistance
A number of countries and foundations pledged EUR 56.5 million to help develop new treatments to fight against antibiotic resistance, during a fundraising event for the Global Antibiotic Research and Development Partnership (GARDP).NTrans Technologies receives Horizon 2020 SME grant
NTrans Technologies today announced it has been awarded a prestigious, €1.5M EU SME instrument grant.Her Majesty Queen Máxima will attend World of Health Care
Her Majesty Queen Máxima will be present at the World of Health Care congress on the 28th of September in the Fokker Terminal in The Hague. During this congresstival, the central theme is improving healthcare globally.
Mimetas Develops High-Throughput Gut-on-a-chip Technology in Collaboration with Roche
Mimetas, in collaboration with the pharmaceutical company Roche, has developed a novel organ-on-a-chip system that supports evaluation of intestinal permeability in perfused 3D gut tubules in high throughput under exposure to pharmacological compounds. The results of this research were published in the scientific journal Nature Communications.Top Sector Life Sciences & Health presents new Knowledge and Innovation Agenda: Grow~Motion
Today Health~Holland, Top Sector Life Sciences & Health (LSH), launches the Knowledge and Innovation Agenda 2018-2021 titled Grow~Motion. This new strategic document describes the health and care ambitions for the next four years (2018-2021).
Dutch industry strengthens its competitiveness through cooperation
De samenwerking tussen bedrijven, kennisinstellingen en de overheid is versterkt dankzij de topsectorenaanpak. Door private en publieke middelen gerichter in te zetten wegen de voordelen van de topsectorenaanpak op tegen de investeringen. Dit is een van de conclusies van het onderzoeksbureau Dialogic dat een evaluatie uitvoerde naar de effecten van de topsectorenaanpak.Human Metabolome Technologies chose Leiden for its European office
Japanese firm Human Metabolome Technologies (HMT) has chosen Leiden for its European office and started operations July 1st 2017 at the Leiden Bio Science Park. This biotechnology company develops capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technologies and solutions to drive drug discovery, diagnosis, and food production.Pharming announces publication of Ruconest prophylactic data in The Lancet
Pharming Group announced The Lancet has published data from a Phase II, double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of Ruconest for the prevention of hereditary angioedema attacks.Arterial stiffness now measured within 2 minutes
Until now, vascular elasticity could only be measured with large, expensive equipment in hospitals. To bring the technique closer to the patient, VitaK, has developed the “Stiffnograph”, a new, portable medical device. With the help of the StiffnoGraph, care providers are able to monitor non-invasively the stiffness of the large arteries within 2 minutes.